CD14 and myelodysplastic syndrome: In PMNLs of patients with myelodysplastic syndromes, stem cell malignancies with an increased risk of developing acute myeloid leukemia deficient in formin proteins involved in linear actin polymerization show a specific increase of CD14 messenger RNA [29].